Hello guys, Welcome to Africa's Largest Video Search Engine, and you are watching Dr. Nadir Ali - 'Do statins prevent or cause heart disease? Should LDL be called "bad" Cholesterol?'. and this video is uploaded by Low Carb Down Under at 2020-06-27T16:33:03-07:00. We are just promoting this video only for entertainment and educational purpose only. I hop you like our Video Search Engine. [o_QdNX9etCg]
| Name | Dr. Nadir Ali - 'Do statins prevent or cause heart disease? Should LDL be called "bad" Cholesterol?' |
| Video Uploader | Video From Low Carb Down Under |
| Upload Date | This Video Uploaded At 27-06-2020 23:33:03 |
| Video Discription | Dr. Nadir Ali is an interventional cardiologist with over 25 years of experience. He is also the chairman of the Department of Cardiology at Clear Lake Regional Medical Center. Before working as a cardiologist, he served as an assistant professor of medicine for eight years at Baylor College of Medicine in Houston, where he also received his medical training. Dr. Ali has championed many aspects of the science and practice of a low-carb lifestyle in the local Clear Lake area since 2013. He organises a monthly nutritional seminar in the Searcy Auditorium of the Clear Lake Hospital that receives more than 100 visitors every month from the local community. Dr Ali’s focus is on managing heart disease, obesity, metabolic syndrome and diabetes. Please consider supporting Low Carb Down Under via Patreon. A small monthly contribution will assist in the costs of filming and editing these presentations and will allow us to keep producing high quality content free from advertising. For further information visit; https://www.patreon.com/lowcarbdownunder [o_QdNX9etCg] |
| Category | Science & Technology |
| Tags | Low Carb Down Under | LCDU | www.lowcarbdownunder.com.au | Low Carb Denver 2020 | #LCD2020 | #LowCarbDenver | Nadir Ali | @eatmostlyfatali | CVD | statins | LDL cholesterol | heart disease | cardiovascular disease | lipoproteins | HDL | dolichol | CoQ10 | ATP | Pravastatin | Big Pharma | PCSK9 Inhibitors | Abetalipoproteinemia | Chylomicrons |
